PsyBio Therapeutics

PsyBio Therapeutics is an intellectual property-driven biotechnology company focused on the discovery and development of novel psycho-targeted therapies aimed at improving mental health and neurological disorders. The team has extensive experience in drug discovery based on synthetic biology and metabolic engineering, as well as clinical and regulatory expertise in advancing drugs through human studies and regulatory protocols. Currently, they are researching and developing naturally occurring psychoactive tryptamines initially found in various species of psychedelic mushrooms, other tryptamines and phenethylamines, and their combinations. The company employs a bio-medicinal chemistry approach for therapeutic development, where psychoactive compounds can serve as templates for developing both natural and non-naturally occurring precursors and analogs.